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Abstract
Objective: To determine the efficacy of inferior turbinate coblation for the treatment of nasal obstruction.
Methods: Twenty patients awaiting submucosal diathermy to the inferior turbinates were recruited into
the study. All underwent inferior turbinate coblation. Pre-operative and post-operative nasal function was
investigated using posterior rhinomanometry and subjective symptom scales.
Results: There was no significant increase in nasal conductance two weeks after inferior turbinate
coblation (p ¼ 0.159). However, three months after inferior turbinate coblation, median nasal
conductance had increased significantly, from 203 to 324 cm3/s (p ¼ 0.004). The median increase in nasal
conductance was 73 cm3/s or 43.5 per cent. Post-operative visual analogue patients’ reported
post-operative visual analogue scales scores for nasal obstruction decreased significantly, both two weeks
(p ¼ 0.006) and three months after inferior turbinate coblation (p ¼ 0.001) when compared to Pre-
operative values. There was no change in the reported severity of rhinorrhoea, nasal itching or sneezing.
There was a significant relationship (r ¼ 20.57, p ¼ 0.014) between pre-operative nasal conductance and
change in nasal conductance after inferior turbinate coblation.
Conclusions: This study confirms the short-term efficacy of inferior turbinate coblation for the treatment of
nasal obstruction. The benefit was greatest in patients with lower pre-operative nasal conductance. Objective
measures of nasal obstruction may be important when selecting patients for inferior turbinate coblation.
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Introduction
Nasal obstruction due to inferior turbinate enlarge-
ment is a common problem. There are many surgical
treatments for turbinate enlargement, but little objec-
tive evidence to support their efficacy. Inferior turbi-
nate coblation is a relatively new, submucosal
technique that involves the use of a bipolar wand
and a standard electrosurgical unit known as the
Coblatorw surgery system (ArthroCare, Harrogate,
UK). An electrically conductive fluid is employed in
the gap between the electrode and the tissue. It is
claimed that this results in the ‘non-thermal volumetric
removal of tissue’.1 To date, few published studies
have reported the use of inferior turbinate coblation
for the treatment of nasal obstruction.2–4 Subjective
improvement in the frequency and severity of nasal
obstruction has been reported following inferior turbi-
nate coblation.2,3 However, there is conflicting evi-
dence concerning the objective improvement in nasal
obstruction after inferior turbinate coblation.2
It is important that surgical efficacy is determined
using an objective measure of nasal obstruction.
This is because the subjective sensation of nasal
airflow is influenced by many factors, including
mood, cold receptors and congestion of the ostia of
the paranasal sinuses.5 Surgery aims simply to
unblock the nose, so it seems entirely appropriate
that an objective measurement of nasal airflow is
used for evaluation. This study evaluated the efficacy
of inferior turbinate coblation using posterior rhino-
manometry to provide measurements of total nasal
conductance of airflow. Rhinomanometry is gener-
ally accepted as the ‘gold standard’ technique for
assessing nasal obstruction.6 Posterior rhinomano-
metry has the advantage of enabling direct measure-
ment of total nasal conductance of airflow, and also
permits measurement when there is total unilateral
airway obstruction.
Methods
Ethical considerations
The study was approved by the south east Wales
research ethics committee and the Cardiff and Vale
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National Health Service trust research and develop-
ment office. All patients provided informed consent
in order to participate.
Participants
All patients on the University Hospital of Wales
waiting list for submucosal diathermy to the inferior
turbinates were invited to take part in the study.
Patients aged 18 years or more with nasal obstruction
as their main nasal symptom and with no previous
history of nasal surgery were eligible for inclusion.
Patients were excluded if they had a severe septal
deviation or other condition that could cause nasal
obstruction, such as nasal polyps, or if they were
drug or alcohol abusers.
Patients who fulfilled the entry criteria for the
study were assessed using subjective symptom sever-
ity scores and posterior rhinomanometry. Patients
were scheduled for inferior turbinate coblation and
were reviewed two weeks and three months post-
operatively. Participants provided symptom severity
scores and had their nasal conductance measured at
each post-operative visit.
Objective and subjective measurements of nasal
obstruction
Nasal obstruction wasmeasured using posterior rhino-
manometry and symptom severity scale scores.
Patients completed their symptom severity scores
before having their nasal conductance measured in
order to avoid bias. Patients were asked to refrain
from consuming menthol-containing medications
and more than four units of alcohol for 24 hours
prior to each assessment. They were also requested
to avoid oral and nasal decongestants for 48 hours
prior to each assessment, and nasal steroids and anti-
histamines for two weeks before each assessment. To
avoid other confounding factors in the measurement
of nasal obstruction, patients who had had an upper
respiratory tract infection within two weeks of the
assessment had their appointment rescheduled.
Posterior rhinomanometry
Total nasal conductance of airflowwasmeasured using
posterior rhinomanometry using the NR6-2 rhino-
manometer (GM Instruments, Glasgow, Scotland,
UK) at a sample pressure of 75 Pa. The rhinomano-
meter was calibrated daily. Participants were asked
to gently blow their nose prior to each measurement
to clear any secretions. Participants were trained to
breathe into the facemask whilst sealing their lips
around the pressure sensing tube in the oral cavity.
Participants were asked to breathe at a normal rate
and depth, and two consecutive sets of four respiratory
cycles were obtained. After the first set of four breaths
was completed, the participant was requested to rest,
remove the facemask and replace it again before
delivering the second set of breaths. The coefficient
of variation (CV) was calculated after the second set
of breaths, and patients were required to achieve a
CV of 10 per cent or less. The mean nasal resistance
of the eight respiratory cycles was than calculated.
Participants were given three attempts to achieve a
CV of 10 per cent or less. Nasal conductance of
airflow was calculated by dividing the sample pressure
by the mean total nasal resistance. Patients who pre-
sented with complete nasal obstruction were deemed
to have a nasal conductance of 0 cm3/s.
Symptom severity scales
A 100mm visual analogue scale (VAS) anchored by
the descriptors ‘nose completely clear’ (0 mm) and
‘nose completely blocked’ (100 mm) was used to
assess present subjective severity of nasal obstruction.
The severity of nasal obstruction over the past week
was scored on a four-point ordinal scale (symptom
not present ¼ zero, mild symptoms¼ one, moderate
symptoms ¼ two and severe symptoms¼ three). The
subjective severities of rhinorrhoea, nasal itching
and sneezing over the previous week were also
scored on a four-point ordinal scale.
Operative technique
The surgery was performed in accordance with a
standard operating procedure, by two surgeons
(SEJF and SMQ). Guided by the advice of the
attending doctor, participants were given the option
to have the surgery performed under local or
general anaesthesia in the operating theatres at the
University Hospital of Wales, Cardiff.
The patient was positioned supine with 308 of head
elevation. The nose was prepared using a standard
technique with the application of cocaine paste, and
each inferior turbinate was infiltrated with 2 per
cent lidocaine with 1:80 000 adrenaline.
The surgery was performed using a Coblator II
surgery system and a ReFlex Ultra
TM
45 wand
(ArthroCare) set at power level four. The wand was
activated and the anterior end of the inferior turbi-
nate was pierced with the wand tip. The wand was
then advanced submucosally, whilst still activated,
to the second or third marker, depending on the
size of the turbinate, to create a tissue channel. Ten-
second periods of activation were performed at each
marker depth to create a series of two or three
lesions, depending on the depth of insertion. A
further one or two channels were created, depending
on the size of the inferior turbinate.
Post-operatively, patients were recommended to
use analgesia as necessary and were provided with
a routine prescription. They were advised to use
regular saline douches and to discontinue all other
topical nasal medication.
Statistical analysis
Statistical analysis of results was performed using
Wilcoxon’s test. Spearman’s rank correlation coeffi-
cient was used to determine the relationship
between variables. A p value of 0.05 was deemed
to be statistically significant.
Where results are presented as box plots, the
median value is indicated by a thick black line. The
interquartile range is demonstrated by a shaded box
ranging from the 25th to the 75th percentile. Whiskers
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at the end of the box are constructed according to
Tukey’s method; they show the largest and smallest
observed values that are less than 1.5 box lengths
from either end of the box.
Results
Twenty patients were recruited into the study. One
patient was excluded during the follow-up period
because he developed nasal polyps. Of the 19
patients included in the study, 18 had inferior turbi-
nate coblation performed under general anaesthesia.
One patient had coblation performed under local
anaesthesia due to suspicion of malignant hyperther-
mia. One patient failed to attend for his three-month
follow-up appointment, but his two-week follow-up
results were included in the study.
The patients comprised 14 men (74 per cent) and
five women (26 per cent). The mean age of the
study population was 32 years (range 19 to 59
years). Five patients (26 per cent) had documented
evidence of allergy in the form of positive skin
prick tests to commonly inhaled allergens.
Two weeks after inferior turbinate coblation, 13
patients (68 per cent) had an increased nasal conduc-
tance of airflow. By three months post-operatively,
15 patients (83 per cent) had an increased nasal con-
ductance of airflow. The median pre-operative nasal
conductance was 203 cm3/s (range 0–615 cm3/s,
Figure 1). The median nasal conductance two
weeks after inferior turbinate coblation was
250 cm3/s (range 175–475 cm3/s); three months
after surgery, it was 324 cm3/s (90–560 cm3/s).
There was no significant difference in nasal conduc-
tance two weeks after surgery compared with
pre-operative values (p ¼ 0.159). Three months
after surgery, nasal conductance was significantly
greater than pre-operative values (p ¼ 0.004). The
median change in nasal conductance three months
after coblation was an increase of 73 cm3/s (range
2108 to 279 cm3/s) or 43.5 per cent (range 218 to
279 per cent).
Fifteen patients (79 per cent) reported lower VAS
scores two weeks after surgery, compared with pre-
operative scores. Three months after coblation, 14
patients (78 per cent) reported lower VAS scores
for nasal obstruction, compared with pre-operative
scores. The median VAS score for nasal obstruction
before inferior turbinate coblation was 78 mm
(range 29–100 mm, Figure 2). Two weeks after
surgery, the median VAS score was 50 mm (range
0–81 mm); three months after surgery, it was
31.5 mm (range 5–81 mm). The VAS score for
nasal obstruction reported two weeks after cobla-
tion was significantly lower than the pre-operative
score (p ¼ 0.006), as was the VAS score for nasal
obstruction reported three months after surgery
(p ¼ 0.001).
The VAS scores for nasal obstruction reported two
weeks and three months after coblation were signifi-
cantly lower than the pre-operative scores (p ¼
0.046 and p ¼ 0.001, respectively). There was no sig-
nificant change in the reported severity of rhinor-
rhoea, nasal itching or sneezing following inferior
turbinate coblation.
There was a significant relationship between pre-
operative nasal conductance of airflow and change
in nasal conductance of airflow three months after
inferior turbinate coblation (Figure 3). Spearman’s
correlation coefficient was 20.57 (p ¼ 0.014).
Discussion
Cottle7 recognised the importance of obtaining
objective measurements of nasal obstruction back
in the 1960s, and concluded that ‘. . . just as clearly
FIG. 2
Effect of inferior turbinate coblation on VAS score for nasal
obstruction. See text for explanation of boxes and whiskers.
Pre-op ¼ pre-operative; post-op ¼ post-operative; wks ¼
weeks; mths ¼ months
FIG. 1
Effect of inferior turbinate coblation on total nasal
conductance of airflow. See text for explanation of boxes and
whiskers. Pre-op ¼ pre-operative; post-op ¼ post-operative;
wks ¼ weeks; mths ¼ months
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as the ear surgeon needs audiometry pre- and
post-operatively, the nose surgeon needs rhinomano-
metry’. Unfortunately, there continues to be little
objective evidence for the efficacy of surgical treat-
ments for nasal obstruction. Back et al.2 attempted
to objectively assess the outcome of inferior turbi-
nate coblation in a group of 20 patients with nasal
obstruction, using anterior rhinomanometry and
acoustic rhinometry. However, although there was
an increase in nasal cavity volumes six months and
one year after inferior turbinate coblation, there
was no difference three months after the surgery.
There was no significant difference in nasal conduc-
tance after inferior turbinate coblation. Given these
findings, the objective evidence concerning the effi-
cacy of inferior turbinate coblation is unclear.
Total nasal conductance of airflow is the most rel-
evant functional measurement of the airway8 and is
best measured with posterior rhinomanometry.
Anterior rhinomanometry, calculated from unilat-
eral values using Ohm’s law of parallel resistors,
cannot measure total nasal conductance of airflow.
The validity of this technique has been questioned
due to a lack of similarity between calculated and
measured values.9
The present study showed a significant improve-
ment in median total nasal conductance three
months after inferior turbinate coblation, equivalent
to a median increase in nasal conductance of airflow
of 43.5 per cent. This conflicts with the findings of the
only other published study2 addressing the objective
results of turbinate coblation surgery. This may be
explained by differences in the techniques used to
obtain the objective measurements. Back et al.2 not
only used anterior rhinomanometry, as opposed to
the posterior rhinomanometry used in our study,
but also failed to clearly describe their technique
for obtaining measurements. The median nasal
resistance of patients in Back and colleagues’ study
was less than 0.20 Pa/cm/second.2 This is within
the normal range, which is typically reported to be
less than 0.23 Pa/cm/second.10 This raises issues
about patient selection for this study. In comparison,
in our study the median nasal conductance was
203 cm3/s, which is equivalent to a nasal resistance
of 0.37 Pa/cm/second.
There was no significant difference in nasal con-
ductance of airflow, comparing pre-operative and
early post-operative (two-week) assessments. This
may be due to the small number of patients. Few
other studies have examined the objective benefit
of turbinate electrosurgery in the early post-
operative period. Rhee et al.11 operated upon 16
patients using radiofrequency tissue reduction, and
used rhinomanometry to measure nasal resistance
at days one, two and three and weeks one, four and
eight post-operatively. They found no significant
improvement, compared with pre-operative nasal
resistance values, until eight weeks after surgery.
This may be explained by the early tissue response
to the trauma of surgery, which comprises an inflam-
matory phase, a lag phase and a proliferative phase.12
In the nasal mucosa, this characteristically results in
oedema, rhinorrhoea and crusting during healing.
Another potential explanation for the lack of objec-
tive improvement two weeks after coblation is that
the surgery results in a progressive reduction in the
volume of turbinate tissue post-operatively because
fibrosis develops slowly.
This study demonstrated a significant improve-
ment in patients’ subjective scores for nasal
obstruction two weeks after surgery, compared
with pre-operative scores. This improvement was
maintained three months post-operatively. Other
studies have also shown subjective improvement
in the severity of nasal obstruction after inferior
turbinate coblation.2,3 Back et al.2 used a similar
100 mm VAS but unfortunately did not report any
values to enable a direct comparison with the
present study.
There are a number of potential explanations as
to why there was subjective improvement in nasal
obstruction two weeks after inferior turbinate
coblation but no improvement in nasal conductance
of airflow. The small sample size may be respon-
sible, or the multifactorial nature of the sensation
of nasal airflow. Alternatively, the early subjective
improvement in nasal blockage may be explained
by the placebo effect of surgery. This explanation
is supported by the fact that 68 per cent of patients
experienced an improvement in nasal conductance
two weeks after surgery, but that 79 per cent of
patients experienced a subjective improvement in
nasal obstruction. Patients seemed to over-rate the
efficacy of the surgery two weeks post-operatively.
Inclusion in this study might also bias subjective
scores, if patients felt obliged to score in favour of
inferior turbinate coblation. Alternatively, patients
may perceive an improvement in nasal airflow due
to a reduction in post-operative oedema as overall
improvement in nasal obstruction when this was
not the case. Underlying differences in objective
and subjective scoring may also be relevant. Rhino-
manometry provides a calibrated measure of nasal
FIG. 3
Relationship between pre-operative (pre-op) nasal
conductance of airflow and change in nasal conductance of
airflow three months after inferior turbinate coblation.
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airflow. In contrast, the VAS is not standardised,
although it references extreme values. Measure-
ment is entirely based on patient opinion; thus,
patients may have the same nasal conductance but
their opinion on the severity of their nasal obstruc-
tion may differ, so that they record different VAS
scores.
. There is little objective evidence to support
the efficacy of surgical treatments for inferior
turbinate enlargement
. This study aimed to evaluate the short-term
efficacy of inferior turbinate coblation for the
treatment of nasal obstruction
. There was a significant improvement in nasal
conductance of airflow three months after
inferior turbinate coblation
. Subjective improvements in nasal obstruction
were also recorded after inferior turbinate
coblation
. Patients with the lowest pre-operative nasal
conductance gained most objective benefit
from inferior turbinate coblation
Inferior turbinate coblation did not reduce the
severity of sneezing, nasal itching or rhinorrhoea.
This conflicts with the findings of Back et al., who
showed a significant reduction in VAS scores for
nasal discharge, itching, sneezing and crusting
12 months after coblation.2 The study sample size
was similar to that in our study; the different result
may be explained by chance, by the different VAS
used, or by the different numbers of patients with
allergic rhinitis included in each study. It seems
unlikely that coblation should have an effect on
the severity of nasal symptoms other than
nasal obstruction, as it aims to reduce the size of
the inferior turbinate. (However, it has been
reported that electrosurgery may damage cholinergic
nerves and potentially reduce glandular activity.)13
Bhattacharyya et al.3 concur with the findings of the
present study, reporting no significant improvement
in the severity of postnasal discharge or mucus pro-
duction after coblation surgery.
We found a statistically significant correlation
between pre-operative nasal conductance and
change in nasal conductance after inferior turbinate
coblation. Put simply, patients with the most
blocked noses experienced the greatest improve-
ment in nasal conductance following inferior turbi-
nate coblation. The small number of patients
included in this study limits our ability to draw
firm conclusions from the data. However, it
appears that pre-operative nasal conductance
could potentially be used to determine which
patients are offered inferior turbinate coblation. It
would be possible to determine a cut-off value for
pre-operative nasal conductance with maximal sen-
sitivity and specificity in predicting objective
benefit from surgery. This study suggests that this
cut-off is probably well above the lower limit for
normal nasal conductance. The current method of
selection for turbinate surgery is based on patient
history and subjective assessment of the patient.
This may explain why reports on the efficacy of tur-
binate surgery have been so variable. This study has
shown that if patients were selected for surgery
according to objective pre-operative criteria, then
the potential for improvement in nasal conductance
would be greater. The significant correlation between
pre-operative nasal conductance and change in nasal
conductance after inferior coblation surgery only
serves to reinforce the importance of obtaining objec-
tive measurements of nasal obstruction when assessing
patients with this complaint.
Conclusion
This study provides the first convincing evidence to
support the short-term efficacy of inferior turbinate
coblation. Patients with the lowest pre-operative
nasal conductance of airflow gain greatest objective
benefit from turbinate coblation, and this has poten-
tial implications for the selection of patients for
surgery. This finding also highlights the importance
of obtaining objective measurements of nasal
obstruction when assessing this symptom.
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